Afficher la notice abrégée

dc.contributor.editorAngeloni, Cristina
dc.contributor.editorVauzour, David
dc.date.accessioned2021-05-01T15:16:23Z
dc.date.available2021-05-01T15:16:23Z
dc.date.issued2020
dc.identifierONIX_20210501_9783039362165_385
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/68639
dc.description.abstractNeurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis, are the most common pathologies of the central nervous system currently without a cure. They share common molecular and cellular characteristics, including protein misfolding, mitochondrial dysfunction, glutamate toxicity, dysregulation of calcium homeostasis, oxidative stress, inflammation, and ageing, which contribute to neuronal death. Efforts to treat these diseases are often limited by their multifactorial etiology. Natural products, thanks to their multitarget activities, are considered promising alternatives for the treatment of neurodegeneration. This book deals with two different forms of natural products: extracts and isolated compounds. The study of the bioactivity of the extracts is extremely important as many studies have demonstrated the synergistic effect of the combination of different natural products. On the other hand, the investigation of the activity of specifically isolated natural products can be also important to understand their cellular and molecular mechanisms and to define the specific bioactive components in extracts or foods. This book can be considered an important contribution to knowledge of the neuroprotective effect of natural products and presents a great deal of information, related to both the benefits but also the limitations of their use in counteracting neurodegeneration.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: generalen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciencesen_US
dc.subject.otherVitamin D
dc.subject.otherMultiple Sclerosis
dc.subject.othersymptom
dc.subject.otherneurodegeneration
dc.subject.otheroxidative injury
dc.subject.otherParkinson’s disease
dc.subject.otherterpenes, rotenone
dc.subject.otherthymol
dc.subject.otherAlzheimer’s disease
dc.subject.otherCentella asiatica
dc.subject.otherhippocampus
dc.subject.otherprotein poshophatase 2
dc.subject.otherglycogen synthase kinase 3
dc.subject.otherB-cell lymphoma 2
dc.subject.otherneuroprotection
dc.subject.othernutraceuticals
dc.subject.otherbioavailability
dc.subject.otherstress response
dc.subject.otherneurodegenerative disease
dc.subject.otherbioactive compound
dc.subject.othernatural extract
dc.subject.otherβ-amyloid peptide
dc.subject.othertau protein
dc.subject.otherclinical trial
dc.subject.otherhuman studies
dc.subject.otheranimal studies
dc.subject.otherin vitro studies
dc.subject.othercurcumin
dc.subject.otherfree radicals
dc.subject.otherheme oxygenase
dc.subject.othersafety profile
dc.subject.othertype 2 diabetes
dc.subject.otherinflammation
dc.subject.othervascular damage
dc.subject.otherlearning
dc.subject.othermemory
dc.subject.othernatural compound
dc.subject.otheroxidative stress
dc.subject.othercognitive dysfunction
dc.subject.othercell death
dc.subject.othersynapse loss
dc.subject.otherprotein aggregation
dc.subject.otherneuroinflammation
dc.subject.otheralgae
dc.subject.otherseaweeds
dc.subject.otherneurodegenerative diseases
dc.subject.otherauraptene
dc.subject.otherdopamine neuron
dc.subject.otherantioxidant
dc.subject.othermitochondria
dc.subject.otherChionanthus retusus
dc.subject.otherflavonoid
dc.subject.otherflower
dc.subject.otherHO-1
dc.subject.otherNO
dc.subject.otherLippia citriodora
dc.subject.otherVEE
dc.subject.otherVs
dc.subject.otherrelaxation
dc.subject.otherdepression
dc.subject.othercyclic AMP
dc.subject.othercalcium
dc.subject.otherblood–brain barrier
dc.subject.othercatechin
dc.subject.othercognition
dc.subject.otherepigallocatechin gallate
dc.subject.othergreen tea
dc.subject.othermicrobiota
dc.subject.other5-(3,5-dihydroxyphenyl)-γ-valerolactone
dc.subject.otherascaroside pheromone
dc.subject.otherC. elegans
dc.subject.otherdauer
dc.subject.otherneuronal signaling
dc.subject.othersexual behavior
dc.subject.othersurvival signals
dc.subject.otherproteostasis
dc.subject.otherchaperones
dc.subject.otherautophagy
dc.subject.otherubiquitin-proteasome
dc.subject.otherunfolded protein response
dc.subject.othernatural compounds
dc.subject.othernatural products
dc.subject.otherethics
dc.subject.otherpatients’ autonomy
dc.subject.otherbeneficence
dc.subject.othernonmaleficence
dc.subject.othermedical liability
dc.subject.otherParkinson’s disease (PD)
dc.subject.othermitochondrial dysfunction
dc.subject.otherdynamics
dc.subject.otherhormesis
dc.subject.otherubiquitin‒proteasome system (UPS)
dc.subject.othermitophagy
dc.subject.othern/a
dc.titleNatural Products and Neuroprotection
dc.typebook
oapen.identifier.doi10.3390/books978-3-03936-217-2
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783039362165
oapen.relation.isbn9783039362172
oapen.pages338
oapen.place.publicationBasel, Switzerland


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/